Member Info for nomlungu

VAL401 is already subject to a JV

https://www.valirx.com/valiseek/valiseek-overview/

Take care and enjoy your cooler night.

Per the last full year accounts - they lost £3.5M despite R&D credits and interest on their reduced cash balance of £2.7M.

There have been 2 placings since the end of the last financial year - cash is being burnt - why else would I post that comment?

The Imfinzi trial has cost many millions of coconuts.

Regards

Hardman’s company research is paid for by the companies about which we write and, as such, falls within the scope of ‘minor non-monetary benefits’, as defined in the Markets in Financial Instruments Directive II.

I like the science here but, there is no income in the accounts, other than interest and r and d tax credits [ unless you consider the increasing placing price despite the dilution a positive ].

Are there any milestones that I have missed that will generate any revenue in the next couple of years [ other than the mythical take over / buy out / joint venture/ new IPO etc? ].

Obelix,

What compound are you expecting the JV to encompass?

Latino,

Human CD markers and their associated antigens seem more likely to find answers to me - it is why I prefer human models.

https://docs.abcam.com/pdf/immunology/Guide-to-human-CD-antigens.pdf

This link may interest some:

https://docs.abcam.com/pdf/immunology/Guide-to-human-CD-antigens.pdf

Chemerin Project - it is a mice model

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320080/

BAM-8 - read the report youself

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3111068/

I do not trust the interoperability of mice to rabbit to human models because of the mis-shaped protein shards

Noise - it is only partially effective and costs $10k per year per patient. It shows the scope and market value for a more effective medication which Valirx may or may not have.

The FDA has just approved a new endometriosis drug:

https://www.vox.com/2018/7/24/17608984/endometriosis-pain-symptoms-treatments-elagolix-orilissa

More links - I am surprised there has been no answer on this hot July night:

http://scop.berkeley.edu/sunid=50803&ver=1.73

http://scop.berkeley.edu/sunid=48724&ver=1.73

Follow the broken protein shards...

https://duckduckgo.com/?q=protein+shards+dna+rna+&t=h_&ia=web

are any of the posters here aware of and used blast technology?

https://blast.ncbi.nlm.nih.gov/Blast.cgi

A good starting point:

https://duckduckgo.com/?q=cannabis+dopamine+receptors&t=h_&ia=web

This Cold Spring Harbour article is worth reading:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3405830/

C7,

The rabbit models are harder to find.

https://duckduckgo.com/?q=taxid%3A9986&t=h_&ia=web

The link below is to the Blast demo on Youtube [from a Belgium server?]

https://www.youtube.com/watch?v=t8fKz9rvuOk&feature=youtu.be

I had not expected this.

The Basic Local Alignment Search Tool... from my mis-folded protein research. May be of interest to some.

https://blast.ncbi.nlm.nih.gov/Blast.cgi

Human, mouse, rat and microbes... Blast can be run in the cloud

I tried searching to see if / how compatible PSL's technology is compatible with the evolving IEEE standards and found little other than the links below:

http://www.photonstarlighting.co.uk/regulations/flicker_recommendations/

https://www.iop.org/publications/iop/2018/file_71498.pdf

The second link is from the Institute of Physics Report - James McKenzie's report is on pages 34 and 35.

Why do the MMs manipulate this share so much - it is a travesty and the short term speculators just ride the waves. Is this just going to end in tears? I hope not but am begining to wonder if speculating in Myanmar is worth the risk.